RNA Polymerases I and III in development and disease

Semin Cell Dev Biol. 2023 Feb 28:136:49-63. doi: 10.1016/j.semcdb.2022.03.027. Epub 2022 Apr 11.

Abstract

Ribosomes are macromolecular machines that are globally required for the translation of all proteins in all cells. Ribosome biogenesis, which is essential for cell growth, proliferation and survival, commences with transcription of a variety of RNAs by RNA Polymerases I and III. RNA Polymerase I (Pol I) transcribes ribosomal RNA (rRNA), while RNA Polymerase III (Pol III) transcribes 5S ribosomal RNA and transfer RNAs (tRNA) in addition to a wide variety of small non-coding RNAs. Interestingly, despite their global importance, disruptions in Pol I and Pol III function result in tissue-specific developmental disorders, with craniofacial anomalies and leukodystrophy/neurodegenerative disease being among the most prevalent. Furthermore, pathogenic variants in genes encoding subunits shared between Pol I and Pol III give rise to distinct syndromes depending on whether Pol I or Pol III function is disrupted. In this review, we discuss the global roles of Pol I and III transcription, the consequences of disruptions in Pol I and III transcription, disorders arising from pathogenic variants in Pol I and Pol III subunits, and mechanisms underpinning their tissue-specific phenotypes.

Keywords: POLR3-related leukodystrophy; RNA Polymerase I; RNA Polymerase III; Ribosome biogenesis; Treacher Collins syndrome; rRNA.

Publication types

  • Review
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Cycle
  • Humans
  • Neurodegenerative Diseases* / metabolism
  • RNA Polymerase I* / genetics
  • RNA Polymerase I* / metabolism
  • RNA Polymerase III / genetics
  • RNA Polymerase III / metabolism
  • Ribosomes / metabolism
  • Transcription, Genetic

Substances

  • RNA Polymerase I
  • RNA Polymerase III